CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Daniel Brierley - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Daniel Brierley

OPENALEX: A5035201872↗ORCID: 0000-0002-4360-2648↗

Affiliations

Organizations

Food & Nutritionauthorship · NL Language Science (South Korea)authorship · KR University of Readingauthorship · GB

Public evidence

2 connected articles

Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol.2019 · Europe PMC Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats.2016 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.